Retinoids Strongly and Selectively Correlate with Keratin 13 and Not Keratin 19 Expression in Cutaneous Warts of Renal Transplant Recipients

Total Page:16

File Type:pdf, Size:1020Kb

Retinoids Strongly and Selectively Correlate with Keratin 13 and Not Keratin 19 Expression in Cutaneous Warts of Renal Transplant Recipients STUDY Retinoids Strongly and Selectively Correlate With Keratin 13 and Not Keratin 19 Expression in Cutaneous Warts of Renal Transplant Recipients Willeke A. M. Blokx, MD; Jurgen V. Smit, MD; Elke M .G. J. de Jong, MD, PhD; Monique M. G. M. Link; Peter C. M. van de Kerkhof, MD, PhD; Dirk J. Ruiter, MD, PhD Objective: To compare the expression of keratin (K) Results: A significantly higher percentage of warts of 13 and K19 in cutaneous warts of renal transplant re- RTRs expressed K13 compared with warts of ICIs (86% cipients (RTRs) and immunocompetent individuals (ICIs). vs 14%, 18 vs 3 cases, respectively; PϽ.001). In warts of RTRs, retinoid treatment correlated significantly with a Design: Retrospective, nonrandomized immunohisto- particularly strong, segmental K13 expression pattern, chemical study. which we termed zebroid. Without use of retinoids, K13 was mostly restricted to suprabasal single cells. Keratin Patients and Methods: Specimens from cutaneous 19 was absent in all warts of both patient groups. warts of RTRs and ICIs were retrieved from the archives of the Department of Pathology, University Medical Cen- Conclusions: Retinoids strongly correlate with K13 in ter St Radboud, Nijmegen, the Netherlands. Twenty- a characteristic zebroid pattern in warts of RTRs, mak- one warts from RTRs and 21 from ICIs were examined. ing K13 a sensitive marker for retinoid bioactivity in Nine RTRs (10 specimens) received either systemic ac- skin (lesions) of RTRs. In non–retinoid-treated RTRs, itretin or topical all-trans retinoic acid, and their effect K13 is also frequently found in warts but without the on both keratins was assessed. dramatic zebroid pattern noted in retinoid-treated warts. Main Outcome Measures: Frequency and expres- sion patterns of K13 and K19 in warts of RTRs vs ICIs and the effect of retinoids. Arch Dermatol. 2002;138:61-65 PITHELIAL KERATINS com- In the past few years, several murine prise a heterogenous group and in vitro studies have demonstrated that of acidic (type I) and neu- vitamin A and its derivates (retinoids) are tral-to-basic (type II) pro- important regulators of epidermal differ- teins. As a general rule, they entiation and affect keratin gene expres- Eare coexpressed in specific pairings, each sion. In cultured keratinocytes, the induc- pair consisting of a type I and a type II kera- tion of an embryonic type of differentiation tin (K). For instance, in normal adult skin, by retinoids with reinduction of K13 and keratin pairs K5/K14 and K1/K10 pre- K19 expression has been well docu- dominate in the basal layer and the su- mented.5,6 In vivo topical application of prabasal compartment, respectively.1 retinoids on photo-aged human skin also The type I keratins K13 and K19 are showed induction of K13.7 usually expressed separately in adult epi- Although retinoids are used as chemo- thelia. Combined expression occurs only in preventive agents for inhibiting skin cancer fetal skin. Both keratins are thought to be in renal transplant recipients (RTRs),8,9 to absent in normal skin of adults except at cer- the best of our knowledge there are no tain body sites, such as the penile foreskin, studies regarding the effects of retinoids on From the Departments of which still contains K13. Furthermore, K13 keratin expression in the skin or skin le- Pathology (Drs Blokx and is abundantly present in adults in internal sions of these patients. Ruiter and Ms Link) and Dermatology (Drs Smit, stratified epithelia and is associated (with Renal transplant recipients develop de Jong, and van de Kerkhof), terminal differentiation) with suprabasal ex- multiple warts and skin neoplasms. Immu- 1-4 University Medical Center pression. Expression of K19 in adults is nosuppressive treatment, sun exposure, and St Radboud, Nijmegen, the found in simple epithelia, such as most glan- viral infection with human papillomavirus Netherlands. dular epithelia. are all implicated in the etiology of cutane- (REPRINTED) ARCH DERMATOL / VOL 138, JAN 2002 WWW.ARCHDERMATOL.COM 61 ©2002 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 MATERIALS AND METHODS verrucae plana, especially in ICIs, usually on the hands and feet. Condyloma acuminata and anogenital warts were not included. TISSUE SAMPLES IMMUNOHISTOCHEMICAL ANALYSIS For this retrospective immunohistochemical study, we re- trieved formalin-fixed and paraffin-embedded skin speci- Immunohistochemical analysis was performed on all speci- mens from warts of RTRs (21 specimens from 18 patients; mens by using standard avidin-biotin-peroxidase com- average age, 50.8 years; mean duration of immunosuppres- plex system with either diaminobenzidine and/or 3-amino- sion, 16.4 years) and healthy ICIs (21 specimens from 19 9-ethylcarbazole as the chromogens. In brief, 4-µm-thick patients; average age, 33.3 years) from archival material at paraffin sections were deparaffinized, hydrated, and washed the Department of Pathology, University Medical Center in buffered phosphate. St Radboud, Nijmegen, the Netherlands. For K13 staining, sections were cooked in buffered ci- trate (10mM, pH 6.0) in a microwave oven 2 times for 5 RETINOID TREATMENT minutes each (600 W). After a cooling down period of (at least) 20 minutes and preincubation with 20% normal horse Nine RTRs (10 specimens) received retinoids. In 3 pa- serum for 15 minutes, the sections were incubated with un- tients (4 specimens), topical all-trans retinoic acid (con- diluted primary antibody overnight at 4°C. We used 2 mouse centration, 0.025%-0.05%) was used, and 6 patients re- monoclonal primary antibodies, 1C7 (immunoglobulin G2a) ceived systemic acitretin (dose at time of biopsy, 10-35 mg). and 2D7 (immunoglobulin G2b), both recognizing K13.17 Patients taking systemic acitretin participated in a clinical As a positive control, normal esophageal tissue was used. trial, unrelated to the present study, studying the effects After incubation with primary antibodies, sections were in- of systemic retinoids on cutaneous carcinogenesis in RTRs. cubated for 30 minutes with biotinylated horse antimouse Inclusion criteria for this trial were either the presence of (1:200 dilution) (Vector Laboratories, Burlingham, Calif), at least 1 squamous cell carcinoma (SCC) in the patient’s followed by incubation for 45 minutes with avidin-biotin history or the presence of 10 or more actinic keratoses, with complex (1:50 dilution) (Vector Laboratories). For devel- at least 1 confirmed histologically. Initially, most patients opment with 3-amino-9-ethylcarbazole, avidin-biotin com- taking acitretin started with 30 to 35 mg/d, a dosage that plex concentrations were doubled. prevented SCCs in RTRs in an earlier study.8 However, in For K19 immunohistochemical analysis, (mouse) a relatively large number of patients, doses of acitretin had monoclonal antibody RCK 108 (Biogenex, San Ramon, to be lowered because of mucocutaneous adverse effects Calif) was used. Besides different pretreatment (0.1% pro- (peeling of palms and soles and/or cheilitis). Retinoid- and nase for 10 minutes), the same procedure as used for K13 non–retinoid-treated patients showed no obvious differ- was followed. Eccrine ducts and sweat glands served as posi- ences with respect to duration, dosage, and type of immu- tive internal controls. Sections were counterstained with nosuppression, all factors implied in the etiology of skin Mayer hematoxylin for 2 minutes. cancers in immunosuppressed patients (data not shown). Immunoreactivity was scored as negative, slightly posi- tive in a suprabasal single-cell pattern (Ͻ10% lesional ke- HISTOPATHOLOGIC EXAMINATION ratinocytes positive), or strongly positive in a suprabasal segmental columns pattern (zebroid pattern). Scoring was Histologic examination of all studied lesions was revised performed without knowledge of patient history and use according to World Health Organization definitions of ver- of retinoid therapy. rucae.16 The verrucae consisted predominantly of com- The Pearson ␹2 test was used for all statistical analy- mon warts or verrucae vulgares, with a smaller group of ses, and significance was set at PϽ.05. ous tumorigenesis in RTRs.10-14 The frequent simulta- of retinoids on K19 expression in these patients. Retinoid- neous occurrence of warts and skin cancers in RTRs led related K13 expression in epithelial skin lesions of RTRs us to the assumption that the verrucae or warts in RTRs displays a highly characteristic pattern, which we termed might be more prone to become malignant than equiva- zebroid, making K13 a useful marker for evaluating the lent lesions in healthy immunocompetent individuals (ICIs). effect of retinoid treatment in these patients. The existence of high- and low-risk papillomas was pre- viously shown in mice models of cutaneous carcinogen- esis.15 Interestingly, these high-risk papillomas expressed RESULTS K13, which was absent in low-risk papillomas. The present study shows that RTR-associated warts GENERAL ASPECTS OF IMMUNOSTAINING in contrast to warts in normal ICIs indeed show pro- FOR K13 AND K19 nounced K13 expression.This suggests that altered kera- tin expression may reflect an important molecular event In all cases, immunostaining for K13 was restricted to inherent in the malignant degeneration of warts in RTRs. the cytoplasm. Slight variations in staining intensity were Furthermore, this K13 expression in warts of RTRs observed in lesional skin comparing antibodies 1C7 and strongly correlates with retinoid therapy, but, in con- 2D7 with overall stronger staining with the 2D7 anti- trast to findings in animal studies and in cultured hu- body. Principally, however, the staining pattern of le- man keratinocytes,5 we could not demonstrate an effect sional skin with both antibodies was identical. Normal (REPRINTED) ARCH DERMATOL / VOL 138, JAN 2002 WWW.ARCHDERMATOL.COM 62 ©2002 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 Table 1. K13-Positive and K13-Negative Warts in RTRs and ICIs* Warts, No. (%) RTRs ICIs (n = 21) (n = 21) A B K13 positive 18 (86) 3 (14) K13 negative 3 (14) 18 (86) *K13 indicates keratin 13; RTRs, renal transplant recipients; and ICIs, immunocompetent individuals.
Recommended publications
  • Molecular Pathways Associated with the Nutritional Programming of Plant-Based Diet Acceptance in Rainbow Trout Following an Early Feeding Exposure Mukundh N
    Molecular pathways associated with the nutritional programming of plant-based diet acceptance in rainbow trout following an early feeding exposure Mukundh N. Balasubramanian, Stéphane Panserat, Mathilde Dupont-Nivet, Edwige Quillet, Jérôme Montfort, Aurélie Le Cam, Françoise Médale, Sadasivam J. Kaushik, Inge Geurden To cite this version: Mukundh N. Balasubramanian, Stéphane Panserat, Mathilde Dupont-Nivet, Edwige Quillet, Jérôme Montfort, et al.. Molecular pathways associated with the nutritional programming of plant-based diet acceptance in rainbow trout following an early feeding exposure. BMC Genomics, BioMed Central, 2016, 17 (1), pp.1-20. 10.1186/s12864-016-2804-1. hal-01346912 HAL Id: hal-01346912 https://hal.archives-ouvertes.fr/hal-01346912 Submitted on 19 Jul 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Balasubramanian et al. BMC Genomics (2016) 17:449 DOI 10.1186/s12864-016-2804-1 RESEARCH ARTICLE Open Access Molecular pathways associated with the nutritional programming of plant-based diet acceptance in rainbow trout following an early feeding exposure Mukundh N. Balasubramanian1, Stephane Panserat1, Mathilde Dupont-Nivet2, Edwige Quillet2, Jerome Montfort3, Aurelie Le Cam3, Francoise Medale1, Sadasivam J. Kaushik1 and Inge Geurden1* Abstract Background: The achievement of sustainable feeding practices in aquaculture by reducing the reliance on wild-captured fish, via replacement of fish-based feed with plant-based feed, is impeded by the poor growth response seen in fish fed high levels of plant ingredients.
    [Show full text]
  • Supplementary Table 2A. Proband-Specific Variants Proband
    Supplementary table 2A. Proband-specific variants Proband Gene Gene full name Chr Position RefSeqChange Function ESP6500 1000 Genome SNP137 PolyPhen2 Nucleotide Amino acid Score Prediction 1 AGAP5 ArfGAP with GTPase domain, ankyrin repeat and PH domain 5 chr10 75435178 NM_001144000 c.G1240A p.V414M exonic . 0.99 D 1 REXO1L1 REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1 chr8 86574465 NM_172239 c.A1262G p.Y421C exonic . 0.98 D 1 COL4A3 collagen, type IV, alpha 3 (Goodpasture antigen) chr2 228169782 NM_000091 c.G4235T p.G1412V exonic . 1.00 D 1 KIAA1586 KIAA1586 chr6 56912133 NM_020931 c.C44G p.A15G exonic . 0.99 D 1 KIAA1586 KIAA1586 chr6 56912176 NM_020931 c.C87G p.D29E exonic . 0.99 D 1 JAKMIP3 Janus kinase and microtubule interacting protein 3 chr10 133955524 NM_001105521 c.G1574C p.G525A exonic . 1.00 D 1 MPHOSPH8 M-phase phosphoprotein 8 chr13 20240685 NM_017520 c.C2140T p.L714F exonic . 0.97 D 1 SYNE1 spectrin repeat containing, nuclear envelope 1 chr6 152783902 NM_033071 c.A2242T p.N748Y exonic . 0.97 D 1 CAND2 cullin-associated and neddylation-dissociated 2 (putative) chr3 12858835 NM_012298 c.C2125T p.H709Y exonic . 0.95 D 1 TDRD9 tudor domain containing 9 chr14 104460909 NM_153046 c.T1289G p.V430G exonic . 0.96 D 2 ASPM asp (abnormal spindle) homolog, microcephaly associated (Drosophila)chr1 197091625 NM_001206846 c.G3491A p.R1164H exonic . 0.99 D 2 ADAM29 ADAM metallopeptidase domain 29 chr4 175896951 NM_001130705 c.A275G p.D92G exonic . 1.00 D 2 BCO2 beta-carotene oxygenase 2 chr11 112087019 NM_001256398 c.G1373A p.G458E exonic .
    [Show full text]
  • CDH12 Cadherin 12, Type 2 N-Cadherin 2 RPL5 Ribosomal
    5 6 6 5 . 4 2 1 1 1 2 4 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 A A A A A A A A A A A A A A A A A A A A C C C C C C C C C C C C C C C C C C C C R R R R R R R R R R R R R R R R R R R R B , B B B B B B B B B B B B B B B B B B B , 9 , , , , 4 , , 3 0 , , , , , , , , 6 2 , , 5 , 0 8 6 4 , 7 5 7 0 2 8 9 1 3 3 3 1 1 7 5 0 4 1 4 0 7 1 0 2 0 6 7 8 0 2 5 7 8 0 3 8 5 4 9 0 1 0 8 8 3 5 6 7 4 7 9 5 2 1 1 8 2 2 1 7 9 6 2 1 7 1 1 0 4 5 3 5 8 9 1 0 0 4 2 5 0 8 1 4 1 6 9 0 0 6 3 6 9 1 0 9 0 3 8 1 3 5 6 3 6 0 4 2 6 1 0 1 2 1 9 9 7 9 5 7 1 5 8 9 8 8 2 1 9 9 1 1 1 9 6 9 8 9 7 8 4 5 8 8 6 4 8 1 1 2 8 6 2 7 9 8 3 5 4 3 2 1 7 9 5 3 1 3 2 1 2 9 5 1 1 1 1 1 1 5 9 5 3 2 6 3 4 1 3 1 1 4 1 4 1 7 1 3 4 3 2 7 6 4 2 7 2 1 2 1 5 1 6 3 5 6 1 3 6 4 7 1 6 5 1 1 4 1 6 1 7 6 4 7 e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m
    [Show full text]
  • 140503 IPF Signatures Supplement Withfigs Thorax
    Supplementary material for Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis Daryle J. DePianto1*, Sanjay Chandriani1⌘*, Alexander R. Abbas1, Guiquan Jia1, Elsa N. N’Diaye1, Patrick Caplazi1, Steven E. Kauder1, Sabyasachi Biswas1, Satyajit K. Karnik1#, Connie Ha1, Zora Modrusan1, Michael A. Matthay2, Jasleen Kukreja3, Harold R. Collard2, Jackson G. Egen1, Paul J. Wolters2§, and Joseph R. Arron1§ 1Genentech Research and Early Development, South San Francisco, CA 2Department of Medicine, University of California, San Francisco, CA 3Department of Surgery, University of California, San Francisco, CA ⌘Current address: Novartis Institutes for Biomedical Research, Emeryville, CA. #Current address: Gilead Sciences, Foster City, CA. *DJD and SC contributed equally to this manuscript §PJW and JRA co-directed this project Address correspondence to Paul J. Wolters, MD University of California, San Francisco Department of Medicine Box 0111 San Francisco, CA 94143-0111 [email protected] or Joseph R. Arron, MD, PhD Genentech, Inc. MS 231C 1 DNA Way South San Francisco, CA 94080 [email protected] 1 METHODS Human lung tissue samples Tissues were obtained at UCSF from clinical samples from IPF patients at the time of biopsy or lung transplantation. All patients were seen at UCSF and the diagnosis of IPF was established through multidisciplinary review of clinical, radiological, and pathological data according to criteria established by the consensus classification of the American Thoracic Society (ATS) and European Respiratory Society (ERS), Japanese Respiratory Society (JRS), and the Latin American Thoracic Association (ALAT) (ref. 5 in main text). Non-diseased normal lung tissues were procured from lungs not used by the Northern California Transplant Donor Network.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • The Correlation of Keratin Expression with In-Vitro Epithelial Cell Line Differentiation
    The correlation of keratin expression with in-vitro epithelial cell line differentiation Deeqo Aden Thesis submitted to the University of London for Degree of Master of Philosophy (MPhil) Supervisors: Professor Ian. C. Mackenzie Professor Farida Fortune Centre for Clinical and Diagnostic Oral Science Barts and The London School of Medicine and Dentistry Queen Mary, University of London 2009 Contents Content pages ……………………………………………………………………......2 Abstract………………………………………………………………………….........6 Acknowledgements and Declaration……………………………………………...…7 List of Figures…………………………………………………………………………8 List of Tables………………………………………………………………………...12 Abbreviations….………………………………………………………………..…...14 Chapter 1: Literature review 16 1.1 Structure and function of the Oral Mucosa……………..…………….…..............17 1.2 Maintenance of the oral cavity...……………………………………….................20 1.2.1 Environmental Factors which damage the Oral Mucosa………. ….…………..21 1.3 Structure and function of the Oral Mucosa ………………...….……….………...21 1.3.1 Skin Barrier Formation………………………………………………….……...22 1.4 Comparison of Oral Mucosa and Skin…………………………………….……...24 1.5 Developmental and Experimental Models used in Oral mucosa and Skin...……..28 1.6 Keratinocytes…………………………………………………….….....................29 1.6.1 Desmosomes…………………………………………….…...............................29 1.6.2 Hemidesmosomes……………………………………….…...............................30 1.6.3 Tight Junctions………………………….……………….…...............................32 1.6.4 Gap Junctions………………………….……………….….................................32
    [Show full text]
  • Chloride Channels Regulate Differentiation and Barrier Functions
    RESEARCH ARTICLE Chloride channels regulate differentiation and barrier functions of the mammalian airway Mu He1†*, Bing Wu2†, Wenlei Ye1, Daniel D Le2, Adriane W Sinclair3,4, Valeria Padovano5, Yuzhang Chen6, Ke-Xin Li1, Rene Sit2, Michelle Tan2, Michael J Caplan5, Norma Neff2, Yuh Nung Jan1,7,8, Spyros Darmanis2*, Lily Yeh Jan1,7,8* 1Department of Physiology, University of California, San Francisco, San Francisco, United States; 2Chan Zuckerberg Biohub, San Francisco, United States; 3Department of Urology, University of California, San Francisco, San Francisco, United States; 4Division of Pediatric Urology, University of California, San Francisco, Benioff Children’s Hospital, San Francisco, United States; 5Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Heaven, United States; 6Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, United States; 7Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States; 8Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States *For correspondence: Abstract The conducting airway forms a protective mucosal barrier and is the primary target of [email protected] (MH); [email protected] airway disorders. The molecular events required for the formation and function of the airway (SD); mucosal barrier, as well as the mechanisms by which barrier dysfunction leads to early onset airway [email protected] (LYJ) diseases,
    [Show full text]
  • Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant
    Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7,
    [Show full text]
  • Multifaceted Role of Keratins in Epithelial Cell Differentiation and Transformation
    J Biosci (2019) 44:33 Ó Indian Academy of Sciences DOI: 10.1007/s12038-019-9864-8 (0123456789().,-volV)(0123456789().,-volV) Review Multifaceted role of keratins in epithelial cell differentiation and transformation 1,2 1 1,2 1,2 CRISMITA DMELLO ,SAUMYA SSRIVASTAVA ,RICHA TIWARI ,PRATIK RCHAUDHARI , 1,2 1,2 SHARADA SAWANT and MILIND MVAIDYA * 1Vaidya Laboratory, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre (TMC), Kharghar, Navi Mumbai 410210, India 2Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai 400085, India *Corresponding author (Email, [email protected]) MS received 18 September 2018; accepted 19 December 2018; published online 8 April 2019 Keratins, the epithelial-predominant members of the intermediate filament superfamily, are expressed in a pairwise, tissue- specific and differentiation-dependent manner. There are 28 type I and 26 type II keratins, which share a common structure comprising a central coiled coil a-helical rod domain flanked by two nonhelical head and tail domains. These domains harbor sites for major posttranslational modifications like phosphorylation and glycosylation, which govern keratin function and dynamics. Apart from providing structural support, keratins regulate various signaling machinery involved in cell growth, motility, apoptosis etc. However, tissue-specific functions of keratins in relation to cell proliferation and differ- entiation are still emerging. Altered keratin expression pattern during and after malignant transformation is reported to modulate different signaling pathways involved in tumor progression in a context-dependent fashion. The current review focuses on the literature related to the role of keratins in the regulation of cell proliferation, differentiation and transfor- mation in different types of epithelia.
    [Show full text]
  • Loss of Keratin 13 in Oral Carcinoma in Situ: a Comparative Study of Protein and Gene Expression Levels Using Paraffin Sections
    Modern Pathology (2012) 25, 784–794 784 & 2012 USCAP, Inc. All rights reserved 0893-3952/12 $32.00 Loss of keratin 13 in oral carcinoma in situ: a comparative study of protein and gene expression levels using paraffin sections Hiroko Ida-Yonemochi1,2,3, Satoshi Maruyama3, Takanori Kobayashi3, Manabu Yamazaki1, Jun Cheng1 and Takashi Saku1,3 1Division of Oral Pathology, Department of Tissue Regeneration and Reconstruction, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; 2Division of Anatomy and Cell Biology of the Hard Tissue, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan and 3Oral Pathology Section, Department of Surgical Pathology, Niigata University Hospital, Niigata, Japan Immunohistochemical loss of keratin (K)13 is one of the most valuable diagnostic criteria for discriminating carcinoma in situ (CIS) from non-malignancies in the oral mucosa while K13 is stably immunolocalized in the prickle cells of normal oral epithelium. To elucidate the molecular mechanism for the loss of K13, we compared the immunohistochemical profiles for K13 and K16 which is not expressed in normal epithelia, but instead enhanced in CIS, with their mRNA levels by in-situ hybridization in formalin-fixed paraffin sections prepared from 23 CIS cases of the tongue, which were surgically removed. Reverse transcriptase-PCR was also performed using RNA samples extracted from laser-microdissected epithelial fragments of the serial paraffin sections in seven of the cases. Although more enhanced expression levels for K16 were confirmed at both the protein and gene levels in CIS in these seven cases, the loss of K13 was associated with repressed mRNA levels in four cases, but not in the other three cases.
    [Show full text]
  • Effects of Retinoids on the TGF-ß System and Extracellular Matrix In
    J Am Soc Nephrol 12: 2300–2309, 2001 Effects of Retinoids on the TGF-␤ System and Extracellular Matrix in Experimental Glomerulonephritis CHRISTIAN MORATH,* CLAUDIUS DECHOW,* INGO LEHRKE,* VOLKER HAXSEN,* RUDIGER¨ WALDHERR,* JURGEN¨ FLOEGE,† EBERHARD RITZ,* and JURGEN¨ WAGNER* *Department of Nephrology, University of Heidelberg, Heidelberg, Germany; and †Department of Nephrology, University of Aachen, Aachen, Germany. Abstract. Transforming growth factor–␤1 (TGF-␤1) overex- compared with untreated animals (P Ͻ 0.025). Cortical expres- pression plays a key role in the glomerular accumulation of sion of TGF receptor II, but not receptor I gene expression, was extracellular matrix proteins in renal disease. Retinoids have significantly lower in animals treated with all-trans retinoic previously been shown to significantly limit glomerular dam- acid or isotretinoin (P Ͻ 0.05). In all-trans retinoic acid–treated age in rat experimental glomerulonephritis. Therefore, the ef- animals with Thy-GN, the increase of glomerular TGF-␤1 fects of all-trans retinoic acid and isotretinoin on the compo- protein (P Ͻ 0.008) and TGF-␤1(P Ͻ 0.025) and TGF nents of the TGF-␤ system and extracellular matrix proteins in receptor II mRNA (P Ͻ 0.015) was significantly less. Immu- anti-Thy1.1-nephritis (Thy-GN) were investigated. Vehicle- nohistochemistry revealed less glomerular staining for TGF-␤1 injected control rats were compared with rats treated with daily and TGF receptor II in the presence of all-trans retinoic acid. subcutaneous injections of 10 mg/kg body wt all-trans retinoic TGF-␤1 immunostaining was not restricted to monocytes and acid or 40 mg/kg body wt isotretinoin (n ϭ 9 per group) either macrophages, as indicated by double-staining.
    [Show full text]
  • Immunofluorescence Localization of Nuclear Retinoid Receptors In
    Acta Derm Venereol 2004; 84: 363–369 INVESTIGATIVE REPORT Immunofluorescence Localization of Nuclear Retinoid Receptors in Psoriasis Versus Normal Human Skin Teresa KARLSSON, Ola ROLLMAN, Anders VAHLQUIST and Hans TO¨ RMA¨ Department of Medical Sciences, Section of Dermatology and Venereology, Uppsala University, Sweden Psoriasis responds favourably to treatment with retinoids retinoids (1). A second class of retinoid receptors, but the cellular pathways mediating these effects are RXRa,-b and -c, are activated by 9-cis-RA and poorly understood. Retinoids regulate keratinocyte pro- phytanic acid, and function as auxilliary heterodimer- liferation and maturation via binding to nuclear retinoic ization partners for RARs, as well as for the vitamin D acid receptors (mainly RARa and RARc) which form receptor, liver X receptors, peroxisome proliferator- heterodimers with the 9-cis-RA receptor, RXRa.We activated receptors (PPARs) and other members of a have previously shown that mRNA expression of RARa superfamily of nuclear receptors (1). The retinoid- and RXRa is down-regulated in psoriatic lesions as activated RAR-RXR heterodimers recognize and bind compared with non-lesional human skin. In the present to RA-response elements (RAREs) in the promoter study, we investigated the protein expression of RARa, region of certain genes, thereby recruiting co-activators RARc and RXRa in normal and psoriatic skin using leading to transcriptional induction of the adjacent indirect immunofluorescence analysis. Epidermal kerati- gene (1). Retinoids may also interact with other nocytes of normal and non-lesional psoriatic skin signalling pathways, e.g. activator protein-1 (AP-1), displayed similar nuclear localization of all three which has been put forward as a key transcriptional receptors; RARa was detected with decreasing intensity regulator in the expression of many marker genes of from basal to suprabasal layers, RARc showed the keratinocyte differentiation.
    [Show full text]